UNITED STATES ~~SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549~~

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT ~~Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934~~

~~Date~~Pursuant ofto ~~Report~~Section ~~(Date~~13 ~~of earliest event reported~~or 15(d)~~: October 24, 2005~~

of ~~ERGO~~the ~~SCIENCE~~Securities ~~CORPORATION (Exact~~Exchange ~~name~~Act of ~~registrant as specified in its charter)~~1934

Delaware	333-69172	04-3565746
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification Number)
790 Turnpike St., Suite 202 North Andover, MA		01845
(Address of principal executive offices)		(Zip Code)

Date of Report (Date of earliest event reported): September 11, 2006

ERGO SCIENCE CORPORATION

(Exact name of registrant as specified in its charter)

Delaware	333-69172	04-3565746
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification Number)

790 Turnpike St., Suite 202		01845
North Andover, MA		(Zip Code)
(Address of principal executive offices)

Registrant’s telephone number, including area code: (978) 688-8833

Not Applicable ~~(Former name or former address, if changed since last report.)~~

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

o Soliciting material ~~Item~~pursuant ~~5.02 Departure~~to ofRule ~~Directors~~14a-12 orunder ~~Principal~~the ~~Officers;~~Exchange ~~Election~~Act of(17 ~~Directors;~~CFR ~~Appointment of Principal Officers~~240.14a-12)

o Pre-commencement Oncommunications ~~October~~pursuant ~~24,~~to ~~2005,~~Rule ~~J. Warren Huff resigned from the Board of Directors of Ergo Science Corporation~~ 14d-2(~~the “Company”~~b), ~~and~~under ~~from~~ the ~~Audit~~Exchange ~~Committee~~Act ~~and~~(17 ~~Compensation Committee of the Board of Directors of the Company~~CFR 240. ~~Mr. Huff had no disagreements with the Company or its management relating to the Company’s operations, policies or practices.~~14d-2(b))

Ono Pre-commencement ~~October~~communications ~~25, 2005, the Board of Directors of the Company elected Ling Kwok~~ pursuant to ~~the~~Rule ~~Board~~13e-4(c) ofunder ~~Directors of~~ the ~~Company~~Exchange toAct ~~fill~~(17 ~~the~~CFR ~~vacancy left by Mr~~240. ~~Huff’s resignation.~~ 13e-4(c))

MrItem 5.02 ~~Kwok~~Departure ~~has~~of ~~served~~Directors asor ~~Vice~~Principal ~~President,~~Officers; ~~Corporate~~Election ~~Development~~ of ~~the~~Directors; ~~Company~~Appointment ~~since~~of ~~December~~Principal ~~1, 2003~~Officers. From September 2002 until joining the Company he was involved in international charitable work. From February 2000 until September 2002 Mr. Kwok was an investment banker with Pacific Solutions Group. He was also an investment banker with Morgan Stanley & Co. from May 1996 until February 2000. Mr. Kwok received his B.A. degree, with honors, from Trinity College in both economics and Asian studies.

~~SIGNATURE~~On September 11, 2006, Nadim S. Nsouli resigned from the Board of Directors of Ergo Science Corporation (the “Company”), and from the Audit Committee of the Board of Directors of the Company. Mr. Nsouli had no disagreements with the Company or its management relating to the Company’s operations, policies or practices.

~~Pursuant~~On toSeptember 12, 2006, the ~~requirements~~Board of Directors of the Company ~~Securities~~elected ~~Exchange~~Robin ~~Act~~P. ofDummett ~~1934,~~to the ~~registrant~~Board ~~has~~of ~~duly~~Directors ~~caused~~of ~~this~~the ~~report~~Company and to bethe ~~signed~~Audit onCommittee ~~its~~of ~~behalf~~the byBoard of Directors of the ~~undersigned~~Company ~~hereunto~~to ~~duly~~fill ~~authorized~~the vacancy left by Mr. Nsouli’s resignation.

	ERGO SCIENCE CORPORATION
Date: October 28, 2005	By:	/s/ Ling Kwok
		Ling Kwok
		Vice President, Corporate Development

Mr. Dummett was a private equity investor with CVC Capital Partners, a leading private equity firm based in London, England, from January 1998 until April 2004. Mr. Dummett is now a partner of Conversion Capital Partners Limited, an investment fund headquartered in London, England. Mr. Dummett previously qualified as a mechanical engineer from Nottingham University BEng in Nottingham, UK, subsequently working for ICI Plc and PricewaterhouseCoopers where he qualified as an associated chartered accountant.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ERGO SCIENCE CORPORATION

Date: September 13, 2006	By:	/s/ Ling Kwok
		Ling Kwok
		Vice President, Business Development

Filing Compare · ERGO SCIENCE CORP /DE/